Peng Z, Zhang H, Hu H
Adv Exp Med Biol. 2024; 1466:135-159.
PMID: 39546141
DOI: 10.1007/978-981-97-7288-9_10.
Cassano A, Chong A, Alegre M
Front Transplant. 2024; 2:1217065.
PMID: 38993904
PMC: 11235334.
DOI: 10.3389/frtra.2023.1217065.
Baldwin I, Robey E
J Exp Med. 2024; 221(10).
PMID: 38980291
PMC: 11232887.
DOI: 10.1084/jem.20230896.
Yu H, Yang W, Cao M, Lei Q, Yuan R, Xu H
Front Immunol. 2024; 15:1359933.
PMID: 38562929
PMC: 10982411.
DOI: 10.3389/fimmu.2024.1359933.
Yilmazer A, Zevla D, Malmkvist R, Rodriguez C, Undurraga P, Kirgin E
Front Immunol. 2024; 14:1298938.
PMID: 38164128
PMC: 10757929.
DOI: 10.3389/fimmu.2023.1298938.
Same yet different - how lymph node heterogeneity affects immune responses.
Cruz de Casas P, Knopper K, Sarkar R, Kastenmuller W
Nat Rev Immunol. 2023; 24(5):358-374.
PMID: 38097778
DOI: 10.1038/s41577-023-00965-8.
p53 promotes the expansion of regulatory T cells via DNMT3a- and TET2- mediated Foxp3 expression in sepsis.
Zhang H, Wu T, Ren C, Dong N, Wu Y, Yao Y
Burns Trauma. 2023; 11:tkad021.
PMID: 37564681
PMC: 10410290.
DOI: 10.1093/burnst/tkad021.
Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody.
Weaver J, Stack E, Bugge J, Hu C, McGrath L, Mueller A
Oncoimmunology. 2022; 11(1):2141007.
PMID: 36352891
PMC: 9639568.
DOI: 10.1080/2162402X.2022.2141007.
Boosting regulatory T cell function for the treatment of autoimmune diseases - That's only half the battle!.
Schloder J, Shahneh F, Schneider F, Wieschendorf B
Front Immunol. 2022; 13:973813.
PMID: 36032121
PMC: 9400058.
DOI: 10.3389/fimmu.2022.973813.
A Component-Resolved Therapeutic Vaccine for Cockroach Allergy Made of Per a 9 and Transforming Growth Factor-β Homologue, an Immunosuppressive Protein of .
Prangtaworn P, Mahasongkram K, Saeung A, Chaisri U, Seesuay W, Reamtong O
Front Immunol. 2021; 12:676558.
PMID: 34135902
PMC: 8201610.
DOI: 10.3389/fimmu.2021.676558.
Understanding and Targeting Human Cancer Regulatory T Cells to Improve Therapy.
Kolb H, Borcherding N, Zhang W
Adv Exp Med Biol. 2021; 1278:229-256.
PMID: 33523451
DOI: 10.1007/978-981-15-6407-9_12.
Transcriptomic Profiling of Human Effector and Regulatory T Cell Subsets Identifies Predictive Population Signatures.
Hollbacher B, Duhen T, Motley S, Klicznik M, Gratz I, Campbell D
Immunohorizons. 2020; 4(10):585-596.
PMID: 33037096
PMC: 8085975.
DOI: 10.4049/immunohorizons.2000037.
CD70 Inversely Regulates Regulatory T Cells and Invariant NKT Cells and Modulates Type 1 Diabetes in NOD Mice.
Ye C, Low B, Wiles M, Brusko T, Serreze D, Driver J
J Immunol. 2020; 205(7):1763-1777.
PMID: 32868408
PMC: 7787366.
DOI: 10.4049/jimmunol.2000148.
Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3 regulatory T cells.
Mannie M, DeOca K, Bastian A, Moorman C
Cell Immunol. 2020; 355:104173.
PMID: 32712270
PMC: 7444458.
DOI: 10.1016/j.cellimm.2020.104173.
Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients.
Gonzalo Nunez N, Tosello Boari J, Ramos R, Richer W, Cagnard N, Anderfuhren C
Nat Commun. 2020; 11(1):3272.
PMID: 32601304
PMC: 7324591.
DOI: 10.1038/s41467-020-17046-2.
Dawn of Monitoring Regulatory T Cells in (Pre-)clinical Studies: Their Relevance Is Slowly Recognised.
de Wolf A, Herberts C, Hoefnagel M
Front Med (Lausanne). 2020; 7:91.
PMID: 32300597
PMC: 7142310.
DOI: 10.3389/fmed.2020.00091.
A Critical Insulin TCR Contact Residue Selects High-Affinity and Pathogenic Insulin-Specific T Cells.
Bettini M, Scavuzzo M, Liu B, Kolawole E, Guo L, Evavold B
Diabetes. 2019; 69(3):392-400.
PMID: 31836691
PMC: 7034183.
DOI: 10.2337/db19-0821.
Targeting Regulatory T Cells by Addressing Tumor Necrosis Factor and Its Receptors in Allogeneic Hematopoietic Cell Transplantation and Cancer.
Wajant H, Beilhack A
Front Immunol. 2019; 10:2040.
PMID: 31555271
PMC: 6724557.
DOI: 10.3389/fimmu.2019.02040.
FoxP3 in T cell biology: a molecular and structural perspective.
Deng G, Song X, Greene M
Clin Exp Immunol. 2019; 199(3):255-262.
PMID: 31386175
PMC: 7008219.
DOI: 10.1111/cei.13357.
Characterization and Comparison of GITR Expression in Solid Tumors.
Vence L, Bucktrout S, Curbelo I, Blando J, Smith B, Mahne A
Clin Cancer Res. 2019; 25(21):6501-6510.
PMID: 31358539
PMC: 6825542.
DOI: 10.1158/1078-0432.CCR-19-0289.